Monitors FDA, EMA, and MFDS regulatory intelligence for approvals and policy changes.
npx skills add https://github.com/DrMoony/PharmaNova --skill regulatory-radar
Please help me install this Agent Skill. Skill: regulatory-radar Source: https://github.com/DrMoony/PharmaNova/tree/main/.claude/skills/regulatory-radar Command: npx skills add https://github.com/DrMoony/PharmaNova --skill regulatory-radar
This Skill tracks FDA/EMA/MFDS regulatory intelligence, monitoring approval trends, PDUFA, pricing, and policy changes, providing in-depth information and insights for users involved in drug regulation.
Use the regulatory-radar skill to track the latest FDA approval updates for a specific drug.
High-intent search queries and answers about installing and using this skill.
To track FDA drug approval trends and PDUFA dates for regulatory intelligence, you can monitor openFDA data sources to analyze approval updates and ensure clinical trial compliance. This provides in-depth insights for pharmaceutical regulatory affairs professionals.
Monitoring EMA policy changes for market access involves analyzing EMA.europa.eu data sources to evaluate the impact of regulatory updates on clinical trials and drug pricing. This ensures strategic planning and compliance for pharmaceutical companies.
Yes, you can use regulatory intelligence to analyze MFDS approval updates for a specific drug by monitoring MFDS data sources. This tracks approval trends and policy changes to support regulatory affairs professionals in maintaining compliance.
Yes, you need access to openFDA, EMA.europa.eu, and MFDS data sources to monitor regulatory intelligence. Accessing these data sources is required to track approval trends, PDUFA dates, and policy changes effectively.
Regulatory tracking helps with clinical trial design and compliance by analyzing the impact of regulatory changes, such as FDA surrogate endpoint policies, on market access. This ensures trial designs remain competitive and compliant with current standards.
Limitations of regulatory intelligence for pharmaceutical policy analysis include the dependency on accessing openFDA, EMA, and MFDS data sources continuously. Without consistent data source access, tracking approval trends and policy changes may be incomplete or delayed.
robotlearning123Query openFDA API data on drugs, devices, and substances for analysis.
Zeyuyang-0420Generate and validate clinical reports with regulatory compliance checks.
PancrePal-xiaoyibaoSynthesize clinical trial data with TCM diagnostic frameworks to generate personalized health management protocols.
Datus-aiAutomate creation, update, and management of Apache Superset dashboards, charts, and datasets.
